MustGrow Sees Positive Results From Tobacco Field Trials
MustGrow Biologics (CSE: MGRO) this morning reported on results for the use of its mustard-based biopesticide within tobacco field trials.
Read more
MustGrow Biologics
MustGrow Biologics Isolates Third Molecule From Mustard Plant
MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different molecules. The firm this morning
Read more
MustGrow Biologics Sees CannaPM Approved For Use Against Powdery Mildew In Cannabis And Hemp
It appears that revenues might be coming in the near term to MustGrow Biologics (CSE: MGRO). The company announced this
Read more
MustGrow Achieves 100% Economical Control Of Panama Disease, Moves To Field Trials
MustGrow Biologics (CSE: MGRO) has seen further validation of its proprietary mustard derived biopesticide following further laboratory results. The latest
Read more
MustGrow Announces 100% Control Of Root Rot Disease With Patented Biopesticide
MustGrow Biologics (CSE: MGRO) has seen further success with its mustard-derived biopesticide, this morning announcing that third party independent testing
Read more
MustGrow Biologics Sees Positive Soil Health Results In Study
MustGrow Biologics (CSE: MGRO) has seen positive results from a third party confirmatory study related to the active ingredient in
Read more
MustGrow Biologics Receives $1.5 Million From Exercise Of Warrants
MustGrow Biologics (CSE: MGRO) issued a brief news release this morning, indicating that it has bolstered company coffers via the
Read more
Curing The Banana Panama Disease – The Daily Dive feat Colin Bletsky of MustGrow Biologics
Kickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO of MustGrow Biologics (CSE: MGRO).
Read more
MustGrow Sees Executive From Impossible Foods Appointed To Board
MustGrow Biologics (CSE: MGRO) this morning had a major announcement, in that it has appointed Vice President and Chief Accounting
Read more
MustGrow Biologics Updates Market On Its Biopesticide Product Pipeline
MustGrow Biologics (CSE: MGRO) this morning provided an update to the market on the status of its current product pipeline.
Read more